130 related articles for article (PubMed ID: 37756297)
1. Cardiovascular disease risk stratification in the Pakistani population with and without metabolic syndrome: A single centre cross-sectional study.
Palla AH; Fatimi AS; Virani SS; Fatima SS
PLOS Glob Public Health; 2023; 3(9):e0002397. PubMed ID: 37756297
[TBL] [Abstract][Full Text] [Related]
2. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease Risk Score: Results from the Filipino-American Women Cardiovascular Study.
Ancheta IB; Battie CA; Volgman AS; Ancheta CV; Palaniappan L
J Racial Ethn Health Disparities; 2017 Feb; 4(1):25-34. PubMed ID: 27294770
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
[TBL] [Abstract][Full Text] [Related]
5. Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
Zhu L; Singh M; Lele S; Sahakian L; Grossman J; Hahn B; McMahon M
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193947
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
7. Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.
Kandula NR; Kanaya AM; Liu K; Lee JY; Herrington D; Hulley SB; Persell SD; Lloyd-Jones DM; Huffman MD
J Am Heart Assoc; 2014 Oct; 3(5):e001117. PubMed ID: 25277669
[TBL] [Abstract][Full Text] [Related]
8. Ten years risk assessment of atherosclerotic cardiovascular disease using Astro-CHARM and pooled cohort equation in a south Asian sub-population.
Ashraf T; Mengal MN; Muhammad AS; Tareen AK; Khan MN; Kazmi KA; Nadeem A; Sarwar S; Bashir Z; Qamar N; Karim M
BMC Public Health; 2020 Mar; 20(1):403. PubMed ID: 32220240
[TBL] [Abstract][Full Text] [Related]
9. Prevalence by Computed Tomographic Angiography of Coronary Plaques in South Asian and White Patients With Type 2 Diabetes Mellitus at Low and High Risk Using Four Cardiovascular Risk Scores (UKPDS, FRS, ASCVD, and JBS3).
Gobardhan SN; Dimitriu-Leen AC; van Rosendael AR; van Zwet EW; Roos CJ; Oemrawsingh PV; Kharagjitsingh AV; Jukema JW; Delgado V; Schalij MJ; Bax JJ; Scholte AJ
Am J Cardiol; 2017 Mar; 119(5):705-711. PubMed ID: 28024655
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
[TBL] [Abstract][Full Text] [Related]
11. Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system.
Mantri NM; Merchant M; Rana JS; Go AS; Pursnani SK
BMC Cardiovasc Disord; 2022 Dec; 22(1):566. PubMed ID: 36564709
[TBL] [Abstract][Full Text] [Related]
12. Dietary patterns and their associations with the metabolic syndrome and predicted 10-year risk of CVD in northwest Chinese adults.
Hailili G; Chen Z; Tian T; Fu WH; Pei HL; Mahan Y; Luo T; Alimu D; Wang L; Zhang GZ; Liu LR; Wang DL; Dai JH
Br J Nutr; 2021 Sep; 126(6):913-922. PubMed ID: 33256885
[TBL] [Abstract][Full Text] [Related]
13. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
[TBL] [Abstract][Full Text] [Related]
15. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction models for atherosclerotic cardiovascular disease: A systematic assessment with particular reference to Qatar.
Sheikh A; Nurmatov U; Al-Katheeri HA; Ali Al Huneiti R
Qatar Med J; 2021; 2021(2):42. PubMed ID: 34604019
[TBL] [Abstract][Full Text] [Related]
17. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.
Agyekum F; Akumiah FK; Nguah SB; Appiah LT; Ganatra K; Adu-Boakye Y; Folson AA; Ayetey H; Owusu IK
Am J Prev Cardiol; 2024 Jun; 18():100670. PubMed ID: 38655384
[TBL] [Abstract][Full Text] [Related]
19. Applying the Framingham risk score for prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran.
Yousefzadeh G; Shokoohi M; Najafipour H; Shadkamfarokhi M
ARYA Atheroscler; 2015 May; 11(3):179-85. PubMed ID: 26405450
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and 10-year cardiovascular risk among HIV-positive and HIV-negative adults: A cross-sectional study.
Masyuko SJ; Page ST; Kinuthia J; Osoti AO; Polyak SJ; Otieno FC; Kibachio JM; Mogaka JN; Temu TM; Zifodya JS; Otedo A; Nakanjako D; Hughes JP; Farquhar C
Medicine (Baltimore); 2020 Jul; 99(27):e20845. PubMed ID: 32629671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
